Best countries for Peripheral Neuropathy stem cell treatment (2026): cost, regulation & where to go
A planning comparison for Peripheral Neuropathy stem-cell therapy by indicative price, jurisdiction and travel. Provider quality and treatment suitability require separate verification.
Direct answer: Across published 2026 data, Peripheral Neuropathy stem-cell therapy runs roughly €2,300–€4,600 worldwide; Bulgaria is in the lower range of this indicative price dataset for Peripheral Neuropathy. A lower price and EU location do not establish equivalent care; verify evidence, provider credentials, protocol and total scope. There are 50 registered Peripheral Neuropathy stem-cell trials on ClinicalTrials.gov (9 recruiting).
Peripheral Neuropathy stem-cell treatment cost by country (2026)
| Country | Indicative cost | Regulation | Notes |
|---|---|---|---|
| Bulgaria | €3,000–€8,000 | EU member state | Partner-clinic indicative range; verify treatment authorisation, certificates and written quote. |
| Germany | €11,000–€36,700 | EU member state | EU quality, but premium pricing and little price transparency. |
| India | €3,000–€8,000 | Non-EU | Lowest absolute cost; non-EU and long-haul for Western patients. |
| Mexico | €3,000–€12,000 | Non-EU | Affordable but non-EU; quality varies widely between clinics. |
| Turkey | €6,000–€18,000 | Non-EU | Big medical-tourism hub; non-EU, variable regulation. |
| Thailand | €8,000–€20,000 | Non-EU | Wellness-led; very long travel and non-EU. |
| Serbia | €7,000–€31,000 | Non-EU | Popular (Swiss Medica) but non-EU and English-only. |
| Panama | €15,000–€27,000 | Non-EU | Strong science reputation; long-haul and non-EU. |
| USA | €4,600–€46,000 | Non-EU | Mostly experimental; insurance rarely covers regenerative therapy. |
| UK | €4,880–€49,000 | Non-EU | Very limited availability; long private wait. |
| Switzerland | €20,000–€40,000 | Non-EU | Top reputation, highest prices in Europe. |
Indicative ranges compiled from published clinic and medical-tourism pricing, 2026. Cost is only part of the decision — regulation, cell quality and the all-in travel cost matter as much.
Peripheral Neuropathy: choosing a country — common questions
Which is the cheapest country for Peripheral Neuropathy stem cell treatment?
In this indicative dataset, India and Mexico are among the lower-priced markets. Bulgaria is also in the lower range and is an EU member state; verify each provider's current credentials and protocol.
Which EU country is best for Peripheral Neuropathy stem cell therapy?
Published commercial ranges for Germany and Switzerland are often higher than the partner-clinic range in Bulgaria. That does not establish equivalent protocols, authorisation or quality for Peripheral Neuropathy.
Is travelling abroad for Peripheral Neuropathy stem-cell treatment worth it?
It can be, if you choose a regulated clinic and compare the all-in cost (treatment + travel). Use our calculator, and always check whether a registered clinical trial is open first.
Sources & further reading
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
- Open clinical trials for Peripheral Neuropathy (ClinicalTrials.gov) ↗
- Peer-reviewed research on PubMed ↗
- ISSCR patient guide — what to ask ↗
- FDA consumer warning on stem-cell therapies ↗
- EMA — advanced-therapy (ATMP) framework ↗
← Peripheral Neuropathy: stem-cell overview · Peripheral Neuropathy treatment options →
More on this condition
- Peripheral Neuropathy: cell-therapy evidence and registered trials
- How much does stem cell therapy for Peripheral Neuropathy cost? (2026)
- Peripheral Neuropathy stem cell therapy — your questions answered (2026)
- Peripheral Neuropathy: cell-therapy evidence by therapy class
- MSC vs PRP for Peripheral Neuropathy: what the registries show